Challenges in the treatment of dysthymia: a narrative review

L Mathias, LA Quagliato, MG Carta… - Expert Review of …, 2024 - Taylor & Francis
Introduction Despite its milder severity, the chronic nature of dysthymia leads to significant
impairments and functional limitations. The treatment of dysthymia has received considerably …

An update on the pharmacotherapeutic strategies for the treatment of dysthymic disorder: a systematic review

LA Quagliato, D Primavera, M Fornaro… - Expert Opinion on …, 2023 - Taylor & Francis
… acute and maintenance treatments for dysthymia with placebo and standard care in the last
10 … further analysis since they did not compare drugs with a placebo or treatment as usual. In …

Current pharmacotherapeutic approaches for dysthymic disorder and persistent depressive disorder

MG Carta, P Paribello, AE Nardi… - Expert opinion on …, 2019 - Taylor & Francis
… as compared with placebo and also a higher rate of discontinuation due to side effects, with
Tricyclic Antidepressants (TCA) being the most frequently discontinued drugs for this reason. …

Systematic review of clinical practice guidelines for failed antidepressant treatment response in major depressive disorder, dysthymia, and subthreshold depression in …

G MacQueen, P Santaguida… - The Canadian …, 2017 - journals.sagepub.com
… ), subthreshold depression, and dysthymia, are complex … dysthymia is sparse; approximately
half of the trials indicate a superior response to antidepressant medications versus placebo

Major depressive and dysthymic disorders: A review.

JL Calles Jr - Journal of Alternative Medicine Research, 2016 - search.ebscohost.com
… Diagnosis and treatment of dysthymia in children and adolescents. CNS Drugs 2003;17(13):927-46.
[29] Rey JM, Martin A. Selective serotonin reuptake inhibitors and suicidality in …

Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications

E Schramm, DN Klein, M Elsaesser… - The Lancet …, 2020 - thelancet.com
… presentations, including dysthymia with or without … Dysthymia can be difficult to detect in
psychiatric and primary … of persistent depressive disorder including dysthymia, the causation is …

Relationship between placebo response rate and clinical trial outcome in bipolar depression

N Iovieno, AA Nierenberg, SR Parkin, DJH Kim… - Journal of Psychiatric …, 2016 - Elsevier
… From a practical standpoint, given the greatly reduced difference in response to drug versus
placebo for studies with a placebo response rate greater than 30%, we might suggest that in …

From dysthymia to treatment-resistant depression: evolution of a psychopathological construct

A Ventriglio, D Bhugra, G Sampogna… - … Review of Psychiatry, 2020 - Taylor & Francis
… treatments in treating dysthymia: they reported that most drugs, in particular tricyclic agents,
fluoxetine, sertraline, venlafaxine, amisulpride, are superior to placebo in improving the …

Major depressive and dysthymic disorders.

K Elzamzamy, YS Khan - Journal of Alternative Medicine …, 2022 - search.ebscohost.com
… However, a recent study looking into data from the National Surveys on Drug Use and Health
… The prevalence of dysthymic disorders is not well studied. Existing literature is inconclusive …

Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis

C Zangani, B Giordano, HC Stein… - Human …, 2021 - Wiley Online Library
… 2065 patients with a diagnosis of dysthymia (eight studies), … compared to placebo in
individuals with dysthymia (SMD = −… differences between the two drugs either in the reduction in …